CASIA OpenIR  > 中国科学院分子影像重点实验室
Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study
Liu, Fuquan1; Ning, Zhenyuan2,3; Liu, Yanna2; Liu, Dengxiang4; Tian, Jie5; Luo, Hongwu6; An, Weimin7; Huang, Yifei2; Zou, Jialiang2; Liu, Chuan2; Liu, Changchun7; Wang, Lei1; Liu, Zaiyi8; Qi, Ruizhao9; Zuo, Changzeng4; Zhang, Qingge4; Wang, Jitao4; Zhao, Dawei10; Duan, Yongli11; Peng, Baogang12; Qi, Xingshun13; Zhang, Yuening14; Yang, Yongping15; Hou, Jinlin2; Dong, Jiahong16; Li, Zhiwei9,17; Ding, Huiguo14; Zhang, Yu3; Qi, Xiaolong2,16,18
Source PublicationEBIOMEDICINE
ISSN2352-3964
2018-10-01
Volume36Pages:151-158
Corresponding AuthorDing, Huiguo(dinghuiguo@ccmu.edu.cn) ; Zhang, Yu(yuzhang@smu.edu.cn) ; Qi, Xiaolong(qixiaolong@vip.163.com)
AbstractClinically significant portal hypertension (CSPH) is associated with an incremental risk of esophageal varices and overt clinical decompensations. However, hepatic venous pressure gradient (HVPG) measurement, the gold standard for defining CSPH (HVPG >= 10 mm Hg) is invasive and therefore not suitable for routine clinical practice. This study aims to develop and validate a radiomics-based model as a noninvasive method for accurate detection of CSPH in cirrhosis. The prospective multicenter diagnostic trial (CHESS1701, ClinicalTrials.gov identifier: NCT03138915) involved 385 patients with cirrhosis from five liver centers in China between August 2016 and September 2017. Patients who had both HVPG measurement and contrast-enhanced CT within 14 days prior to the catheterization were collected. The noninvasive radiomics model, termed rHVPG for CSPH was developed based on Cr images in a training cohort consisted of 222 consecutive patients and the diagnostic performance was prospectively assessed in 163 consecutive patients in four external validation cohorts. rHVPG showed a good performance in detection of CSPH with a C-index of 0.849 (95%CI: 0.786-0.911). Application of rHVPG in four external prospective validation cohorts still gave excellent performance with the C-index of 0.889 (95%CI: 0.752-1.000,0.800 (95%CI: 0.614-0.986), 0.917 (95%CI: 0.772-1.000), and 0.827 (95%CI: 0.618-1.000), respectively. Intraclass correlation coefficients for inter- and infra-observer agreement were 0.92-0.99 and 0.97-0.99, respectively. A radiomics signature was developed and prospectively validated as an accurate method for noninvasive detection of CSPH in cirrhosis. The tool of rHVPG assessment can facilitate the identification of CSPH rapidly when invasive transjugular procedure is not available. (C) 2018 The Authors. Published by Elsevier B.V.
KeywordPortal hypertension Liver cirrhosis Hepatic venous pressure gradient Radioinics Noninvasive
DOI10.1016/j.ebiom.2018.09.023
WOS KeywordCHRONIC HEPATITIS-C ; PRESSURE-GRADIENT ; LIVER FIBROSIS ; ELASTOGRAPHY ; VARICES ; CANCER ; CARCINOMA ; BIOMARKER ; DISEASE ; IMAGES
Indexed BySCI
Language英语
Funding ProjectNational Natural Science Foundation of China[81600510] ; National Natural Science Foundation of China[81672725] ; Guangdong Science Fund for Distinguished Young Scholars[2018B030306019] ; Guangzhou Industry-Academia-Research Collaborative Innovation Major Project[201704020015] ; Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation[pdjha0096] ; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding[ZYLX201610] ; Beijing Municipal Administration of Hospitals' Ascent Plan[DFL20151602] ; Application Research on Clinical Characteristics of the Capital[z161100000516197] ; Capital's Funds for Health Improvement and Research[2018-1-2081]
Funding OrganizationNational Natural Science Foundation of China ; Guangdong Science Fund for Distinguished Young Scholars ; Guangzhou Industry-Academia-Research Collaborative Innovation Major Project ; Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation ; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding ; Beijing Municipal Administration of Hospitals' Ascent Plan ; Application Research on Clinical Characteristics of the Capital ; Capital's Funds for Health Improvement and Research
WOS Research AreaGeneral & Internal Medicine ; Research & Experimental Medicine
WOS SubjectMedicine, General & Internal ; Medicine, Research & Experimental
WOS IDWOS:000447685300023
PublisherELSEVIER SCIENCE BV
Citation statistics
Cited Times:1[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.ia.ac.cn/handle/173211/23056
Collection中国科学院分子影像重点实验室
Corresponding AuthorDing, Huiguo; Zhang, Yu; Qi, Xiaolong
Affiliation1.Capital Med Univ, Beijing Shijitan Hosp, Dept Intervent Therapy, CHESS Grp, Beijing, Peoples R China
2.Southern Med Univ, State Key Lab Organ Failure Res, Inst Hepatol, CHESS Grp,Hepat Hemodynam Lab,Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
3.Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China
4.Xingtai Peoples Hosp, Xingtai Inst Canc Control, Xingtai, Peoples R China
5.Chinese Acad Sci, Key Lab Mol Imaging, Inst Automat, Beijing, Peoples R China
6.Cent S Univ, Dept Gen Surg, Xiangya Hosp 3, Changsha, Hunan, Peoples R China
7.302 Hosp PLA, Dept Radiol, Beijing, Peoples R China
8.Guangdong Acad Med Sci, Dept Radiol, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China
9.302 Hosp PLA, Dept Gen Surg, Beijing, Peoples R China
10.Capital Med Univ, Dept Radiol, Beijing Youan Hosp, Beijing, Peoples R China
11.Capital Med Univ, Dept Radiol, Beijing Shijitan Hosp, Beijing, Peoples R China
12.Sun Yat Sen Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
13.Gen Hosp Shenyang Mil Area, Dept Gastroenterol, Shenyang, Liaoning, Peoples R China
14.Capital Med Univ, Dept Gastroenterol & Hepatol, Beijing Youan Hosp, Beijing, Peoples R China
15.302 Hosp PLA, Ctr Therapeut Res Hepatocarcinoma, Beijing, Peoples R China
16.Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Hepatopancreatobiliary Ctr, Sch Clin Med, Beijing, Peoples R China
17.Third Peoples Hosp Shenzhen, Dept Hepatobiliary Surg, Shenzhen, Peoples R China
18.Lanzhou Univ, CHESS Frontier Ctr, Lanzhou, Gansu, Peoples R China
Recommended Citation
GB/T 7714
Liu, Fuquan,Ning, Zhenyuan,Liu, Yanna,et al. Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study[J]. EBIOMEDICINE,2018,36:151-158.
APA Liu, Fuquan.,Ning, Zhenyuan.,Liu, Yanna.,Liu, Dengxiang.,Tian, Jie.,...&Qi, Xiaolong.(2018).Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study.EBIOMEDICINE,36,151-158.
MLA Liu, Fuquan,et al."Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study".EBIOMEDICINE 36(2018):151-158.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Liu, Fuquan]'s Articles
[Ning, Zhenyuan]'s Articles
[Liu, Yanna]'s Articles
Baidu academic
Similar articles in Baidu academic
[Liu, Fuquan]'s Articles
[Ning, Zhenyuan]'s Articles
[Liu, Yanna]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Liu, Fuquan]'s Articles
[Ning, Zhenyuan]'s Articles
[Liu, Yanna]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.